The UK’s decision to leave the EU will no doubt
engender a number of changes for the veterinary
medicines industry, which may lead to challenges, but
also to opportunities. Our initial analysis flags up a
number of areas for immediate focus, such as avoiding
legal and regulatory uncertainty, harmonising licensing
systems for veterinary medicines, encouraging further
innovation in our sector and, most importantly, guaranteeing
continued access to the necessary veterinary medicines
that safeguard animal health conveys, according to
Roxanne Feller, Secretary General of IFAH-Europe.